ESLA icon

Estrella Immunopharma

22 hedge funds and large institutions have $33.9M invested in Estrella Immunopharma in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
+1
Holders Change %
+4.76%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
1
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
KIM
1
Karpus Investment Management
New York
$8.63M -$1K -100 -0%
BFM
2
Boothbay Fund Management
New York
$3.9M
ASM
3
ATW SPAC Management
New York
$3.9M
HHGC
4
Hunting Hill Global Capital
New York
$2.9M
CSS
5
Cubist Systematic Strategies
Connecticut
$2.17M +$2.17M +216,895 New
Nomura Holdings
6
Nomura Holdings
Japan
$1.98M
CH
7
CVI Holdings
Delaware
$1.76M
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$1.75M
Goldman Sachs
9
Goldman Sachs
New York
$1.07M
RCM
10
Radcliffe Capital Management
Pennsylvania
$1M
PNC Financial Services Group
11
PNC Financial Services Group
Pennsylvania
$934K
WA
12
Whitebox Advisors
Minnesota
$910K
Citigroup
13
Citigroup
New York
$620K
WRBC
14
W.R. Berkley Corp
Connecticut
$544K
OFG
15
OTA Financial Group
New York
$503K +$56.3K +5,639 +13%
LA
16
Linden Advisors
New York
$416K -$1.24M -123,876 -75%
PCM
17
Pinz Capital Management
New York
$241K
LCM
18
Landscape Capital Management
New Jersey
$207K
Janus Henderson Group
19
Janus Henderson Group
United Kingdom
$174K
SSA
20
Schonfeld Strategic Advisors
New York
$113K
Millennium Management
21
Millennium Management
New York
$100K
WAM
22
Weiss Asset Management
Massachusetts
$100K